Patents by Inventor Christoph Kiziak

Christoph Kiziak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230313256
    Abstract: A method of reducing precipitation in a bacterial fermentation process for producing a fermentation product, which fermentation process comprises the steps: a) cultivating the host cells for bacterial growth in a batch phase using a batch medium; and b) cultivating the host cells for producing the fermentation product in a fed-batch phase using a feed medium; which feed and batch media are each unprecipitated media solutions, wherein: i) the batch medium comprises an amount of calcium salts, magnesium salts, phosphate salts and at least one chelating agent, which is a citrate salt and/or citric acid at an amount of at least 5 mM, and/or EDTA at an amount of at least 1 mM; and ii) the feed medium comprises an amount of calcium salts which is at least 1 mM, and which is at least 5-fold higher as compared to the batch medium (M/M); and iii) the feed medium comprises an amount of magnesium salts which is at least 3 mM, and which is at least 2-fold higher as compared to the batch medium (M/M); and iv) the feed
    Type: Application
    Filed: July 1, 2021
    Publication date: October 5, 2023
    Inventors: Nuria ADELANTADO, Hauke HOLM, Christoph KIZIAK
  • Publication number: 20230126246
    Abstract: A method for producing of a protein of interest (POI) in a yeast host cell that is modified to comprise within one or more expression cassettes heterologous nucleic acid molecules encoding helper factors and a gene of interest (GOI) encoding the POI, wherein: a) a first helper factor comprises at least 90% sequence identity to SEQ ID NO:1; b) a second helper factor comprises at east 90% sequence identity to SEQ ID NO:3; and c) a third helper factor comprises at least 90% sequence identity to SEQ ID NO:5; which method comprises (i) culturing said host cell in a culture medium under conditions to co-express said heterologous nucleic acid molecules and to secrete said POI into the host cell culture; and (ii) recovering the POI from the host cell culture.
    Type: Application
    Filed: April 1, 2021
    Publication date: April 27, 2023
    Inventors: Brigitte GASSER, Rebecca GÖNGRICH, Diethard MATTANOVICH, Christoph KIZIAK
  • Publication number: 20200399325
    Abstract: A eukaryotic host cell engineered to produce a heterologous protein of interest (POI), which cell is genetically modified to reduce production of at least one of three different endogenous host cell protein (HCP), and its use in a method of producing the POI.
    Type: Application
    Filed: January 30, 2019
    Publication date: December 24, 2020
    Inventors: Katrien CLAES, James GRAHAM, Sylwia JOZWIAK, Christoph KIZIAK
  • Patent number: 9970017
    Abstract: The present invention relates to the production of heterologous polypeptides in a recombinant bacterial host cell, wherein the bacterial host cell is rendered unable to deactivate the promoter controlling the expression of the heterologous polypeptide in the absence of an inducer.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: May 15, 2018
    Assignee: Lonza AG
    Inventors: Marian Wenzel, Josef Altenbuchner, Christoph Kiziak
  • Publication number: 20170137830
    Abstract: The present invention relates to the production of heterologous polypeptides in a recombinant bacterial host cell, wherein the bacterial host cell is rendered unable to deactivate the promoter controlling the expression of the heterologous polypeptide in the absence of an inducer.
    Type: Application
    Filed: October 10, 2016
    Publication date: May 18, 2017
    Applicant: Lonza AG
    Inventors: Marian Wenzel, Josef Altenbuchner, Christoph Kiziak
  • Publication number: 20170107525
    Abstract: Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is: a) a nucleic acid sequence which is heterologouse to the host, and b) a prokaryotic signal sequence operably linked to the nucleic acid sequence. The prokaryotic signal sequence is selected from signal peptides of periplasmatic binding proteins for sugars, amino acids, vitamins and ions. The expression of the nucleic acid sequence is controlled by the promoter region. The vector is used for the regulated heterologous expression of a nucleic acid sequence in a prokaryotic host. This is an isolated and purified nucleic acid sequence expressible in a host is the promoter region of the L-rhamnose operon. There is a method for producing a polypeptide in a host using the vector.
    Type: Application
    Filed: March 8, 2016
    Publication date: April 20, 2017
    Inventors: Johann Brass, SR., Christoph Kiziak, Joachim Klein, Ralf Ostendorp
  • Patent number: 9464294
    Abstract: The present invention relates to the production of heterologous polypeptides in a recombinant bacterial host cell, wherein the bacterial host cell is rendered inable to deactivate the promoter controlling the expression of the heterologous polypeptide in the absence of an inducer.
    Type: Grant
    Filed: July 27, 2011
    Date of Patent: October 11, 2016
    Inventors: Marian Wenzel, Josef Altenbuchner, Christoph Kiziak
  • Patent number: 9279128
    Abstract: Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is: a) a nucleic acid sequence which is heterologous to the host, and b) a prokaryotic signal sequence operably linked to the nucleic acid sequence. The prokaryotic signal sequence is selected from signal peptides of periplasmatic binding proteins for sugars, amino acids, vitamins and ions. The expression of the nucleic acid sequence is controlled by the promoter region. The vector is used for the regulated heterologous expression of a nucleic acid sequence in a prokaryotic host. This is an isolated and purified nucleic acid sequence expressible in a host is the promoter region of the L-rhamnose operon. There is a method for producing a polypeptide in a host using the vector.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: March 8, 2016
    Assignee: LONZA AG
    Inventors: Johann Brass, Christoph Kiziak, Joachim Klein, Ralf Ostendorp
  • Patent number: 9163247
    Abstract: The present invention relates to a vector expressible in a prokaryotic host and a nucleic acid sequence comprising a mannose-inducible promoter of the mannose operon of Bacillus subfiles wherein the vector and nucleic acid sequence, respectively, can be suitably used for transforming a host cell for expression of a heterologous nucleic acid sequence coding a polypeptide in, in particular, high cell density fermentation.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: October 20, 2015
    Assignee: Lonza AG
    Inventors: Tianqi Sun, Josef Altenbuchner, Christoph Kiziak
  • Publication number: 20130203114
    Abstract: The present invention relates to the production of heterologous polypeptides in a recombinant bacterial host cell, wherein the bacterial host cell is rendered inable to deactivate the promoter controlling the expression of the heterologous polypeptide in the absence of an inducer.
    Type: Application
    Filed: July 27, 2011
    Publication date: August 8, 2013
    Applicant: LONZA AG
    Inventors: Marian Wenzel, Josef Altenbuchner, Christoph Kiziak
  • Publication number: 20120202246
    Abstract: The present invention relates to a vector expressible in a prokaryotic host and a nucleic acid sequence comprising a mannose-inducible promoter of the mannose operon of Bacillus subfiles wherein the vector and nucleic acid sequence, respectively, can be suitably used for transforming a host cell for expression of a heterologous nucleic acid sequence coding a polypeptide in, in particular, high cell density fermentation.
    Type: Application
    Filed: August 2, 2010
    Publication date: August 9, 2012
    Applicant: LONZA AG
    Inventors: Tianqi Sun, Josef Altenbuchner, Christoph Kiziak
  • Publication number: 20120196323
    Abstract: The present invention relates to a fermentation process for culturing a host cell comprising a vector which comprises an inducible promoter of the mannose operon wherein the inducible promoter of the mannose operon controls expression of a nucleic acid sequence encoding for a polypeptide, in particular the present invention relates to the high cell density fermentation of a prokaryotic host cell comprising the inducible promoter of the mannose operon in the production of a polypeptide.
    Type: Application
    Filed: August 2, 2010
    Publication date: August 2, 2012
    Applicant: LONZA AG
    Inventors: Marian Wenzel, Josef Altenbuchner, Christoph Kiziak, Martin Siemann-Herzberg
  • Publication number: 20120135463
    Abstract: Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is: a) a nucleic acid sequence which is heterologous to the host, and b) a prokaryotic signal sequence operably linked to the nucleic acid sequence. The prokaryotic signal sequence is selected from signal peptides of periplasmatic binding proteins for sugars, amino acids, vitamins and ions. The expression of the nucleic acid sequence is controlled by the promoter region. The vector is used for the regulated heterologous expression of a nucleic acid sequence in a prokaryotic host. This is an isolated and purified nucleic acid sequence expressible in a host is the promoter region of the L-rhamnose operon. There is a method for producing a polypeptide in a host using the vector.
    Type: Application
    Filed: October 14, 2011
    Publication date: May 31, 2012
    Inventors: Johann Brass, Christoph Kiziak, Joachim Klein, Ralf Ostendorp
  • Publication number: 20080206817
    Abstract: Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is: a) a nucleic acid sequence which is heterologouse to the host, and b) a prokaryotic signal sequence operably linked to the nucleic acid sequence. The prokaryotic signal sequence is selected from signal peptides of periplasmatic binding proteins for sugars, amino acids, vitamins and ions. The expression of the nucleic acid sequence is controlled by the promoter region. The vector is used for the regulated heterologous expression of a nucleic acid sequence in a prokaryotic host. This is an isolated and purified nucleic acid sequence expressible in a host is the promoter region of the L-rhamnose operon. There is a method for producing a polypeptide in a host using the vector.
    Type: Application
    Filed: December 5, 2005
    Publication date: August 28, 2008
    Inventors: Johann Brass, Christoph Kiziak, Joachim Klein, Ralf Ostendorp